jueves, 2 de enero de 2020

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer | BMC Cancer | Full Text

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer | BMC Cancer | Full Text

BMC Cancer

Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients.
Authors:Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson and Signe Borgquist
Citation:BMC Cancer 2019 19:1272
Content type:Research article
Published on: 

No hay comentarios:

Publicar un comentario